Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Shchudro (Dnipro, Ukraine), K. Bielosludtseva (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine), L. Konopkina (Dniepropetrovsk, Ukraine). Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features. 3900

Member's Comments

No comment yet.

Related content which might interest you: The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Alcohol effects on diffusing capacity of the lung for carbon monoxide (DLCO) in healthy subjects and in COPD patients Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib Source: International Congress 2016 – IPF treatment II Year: 2016 Mechanisms of exertional dyspnea in patients with mild COPD and low resting lung diffusing capacity for carbon monoxide (DLCO) Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Does carbon monoxide diffusing capacity (DLCO) effect results of pulmonary rehabilitation? Source: International Congress 2015 – Latest insights into pulmonary rehabilitation Year: 2015 Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014 Values of diffusing capacity for carbon monoxide (DLco) in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease – (overlap syndrome) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Exhaled carbon monoxide is decreased in interstitial lung diseases (ILD) Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Diffusing capacity of the lung for carbon monoxide (DLCO) and pulmonary blood flow during incremental and intermittent-work exercise tests Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Does the decrease in KCO go typically with DLCO decrease in obstructive pulmonary diseases? The relationship with DLCO, KCO, VA and VA/TLC in patients with COPD> Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Source: Eur Respir J 2007; 30: 1131-1137 Year: 2007 Carbon monoxide diffusing capacity (DLCO) usefulness in patients suffering from exertional dyspnea with or without oxygen desaturation during exercise testing Source: Eur Respir J 2002; 20: Suppl. 38, 491s Year: 2002 Elevation of diffusing lung capacity (TLCO) in asthmatic children as a result of ventilation/perfusion disorder Source: Eur Respir J 2003; 22: Suppl. 45, 495s Year: 2003 Relationship between diffusing capacity for carbon monoxide and severity of airway obstruction, presence of cor pulmonale chronic in obese and nonobese stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 726s Year: 2006 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013